Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00451958
Status:
COMPLETED
Last Update Posted:
2013-03-21
First Post:
2007-03-23
Brief Title:
A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Organization Data
Organization:
Ferring Pharmaceuticals
Class:
INDUSTRY
Study ID:
FE200486 CS21A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ferring Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None